SCHEMBL6181826

SCHEMBL6181826

COc1cc(OC)c2cc(-c3ccc(O)cc3)c(=O)n(C)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 2/20 0.48
ESRRA P11474 2/20 0.46
HDAC6 Q9UBN7 2/20 0.45
ESR1 P03372 2/20 0.44
ESR2 Q92731 1/20 0.44
ABL1 P00519 2/20 0.43
ABCB1 P08183 2/20 0.43
BCR P11274 2/20 0.43
ALDH2 P05091 1/20 0.43
XDH P47989 1/20 0.43
KLK7 P49862 1/20 0.42
RAB9A P51151 1/20 0.42
EGFR P00533 1/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 3/20 0.41
POLB P06746 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170922 0.91 ALDH1A1 (0.47) ESRRAABL1ABCB1BCRKLK7
SCHEMBL6170336 0.82 KMO (0.44) RETESRRAHDAC6ALDH2XDH
SCHEMBL7813546 0.81 HDAC6 (0.41) HDAC6
SCHEMBL7191760 0.81 DYRK1A (0.43) RETESRRAHDAC6ABL1ABCB1
SCHEMBL7191415 0.75 ESR1 (0.43) RETESRRAHDAC6ESR1ESR2
SCHEMBL6169499 0.75 ABL1 (0.40) ABL1ABCB1BCRKLK7RAB9A
SCHEMBL6170913 0.74 KMO (0.48) KLK7RAB9AKDM4EMAPTPOLB
SCHEMBL6170009 0.73 EGLN1 (0.42)
SCHEMBL6172194 0.73 MEN1 (0.53) RETHDAC6ABL1ABCB1BCR
SCHEMBL6170872 0.72 TDP1 (0.46) KLK7RAB9AKDM4EALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097138-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING 2-QUINOLONES LAFON LABOR (FR) 2005-12-07 EP disclosed
US-6593342-B1 Activity on the proliferation of clonogenic cells in tumours and comprising an efficient amount of a compound selected among the compounds LABORATOIRE L. LAFON (FR) 2003-07-15 US disclosed
EP-1097138-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING 2-QUINOLONES LABORATOIRE L. LAFON (FR) 2001-05-09 EP disclosed
WO-2000003990-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING 2-QUINOLONES LABORATOIRE L. LAFON (FR) 2000-01-27 WO disclosed